Beta Bionics, Inc.
Explore this company’s associated devices, FDA decisions and regulatory history.

Beta Bionics, Inc.
- Regulatory records
- 3
- Linked recall entries
- 0
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 3 FDA records to the applicant name Beta Bionics, Inc.. The collection includes 3 510(k) clearances. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Sep 11, 2026 to Oct 21, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code QFG appears in 2 of the 3 linked filings. The collection spans 2 FDA product codes. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: 11 Hughes, Irvine, CA, 92618, US. Recorded on K263422, decision dated Oct 21, 2026.
Device categories in this collection
Alternate Controller Enabled Insulin Infusion Pump; Interoperable Automated Glycemic Controller.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Devices & associated records
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Mint ACE PumpK263422 | Beta Bionics, Inc. | 510(k) clearance | Oct 21, 2026 | FDA |
Mint ACE PumpK260001 | Beta Bionics, Inc. | 510(k) clearance | Sep 11, 2026 | FDA |
| Beta Bionics, Inc. | 510(k) clearance | Sep 11, 2026 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 19, 2026.

